Hikma Pharmaceuticals Plc Holding(s) in Company (2795K)
April 15 2015 - 4:47AM
UK Regulatory
TIDMHIK
RNS Number : 2795K
Hikma Pharmaceuticals Plc
15 April 2015
Notification of major interests in shares
LONDON, 15 April 2015 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (DIFX: HIK), the fast growing multinational
pharmaceuticals group, announces as follows:
1 Identity of the issuer or the underlying Hikma Pharmaceuticals PLC
issuer of existing shares to which the
voting rights are attached
2 Reason for the notification
An acquisition or disposal of voting rights Yes
--------------------------------------------------------- ----
An acquisition or disposal of financial instruments No
which may result in the acquisition of shares already
issues to which voting rights are attached
--------------------------------------------------------- ----
An event changing the breakdown of voting rights No
--------------------------------------------------------- ----
Other (please specify): Compliance with the Transparency No
Directive
--------------------------------------------------------- ----
3 Full name of the person subject to the The Capital Group Companies,
notification obligation Inc
4 Full name of shareholders Capital Research and Management
Company New World Fund, Inc
---------------------------------------------------------------- --------------------------------------
5 Date of the Transaction (and date on 13 April 2015
which the threshold crossed is reached
differently)
---------------------------------------------------------------- --------------------------------------
6 Date on which the issuer notified 14 April 2015
---------------------------------------------------------------- --------------------------------------
7 Threshold that is crossed 8%
---------------------------------------------------------------- --------------------------------------
8 Notified details See A, B & C below
----- ---------------------------------------------------------------- --------------------------------------
A. Voting rights attached to shares
Class type Situation previous Resulting situation after the triggering
of shares to the triggering transaction
(if possible transaction
using the
ISIN code)
------------------------ -------------------------------------------------------------------
Number Number Number of shares Number of voting % of voting
of shares of voting rights rights
rights
----------- ----------- -------------------- ---------------------- ---------------------
Direct Indirect Direct Indirect Direct Indirect
----------- ----------- ------- ----------- --------- ----------- ------- ------------
Ordinary
Shares (0.10
GBP)
GB00B0LCW083 17,558,981 17,558,981 0 15,899,676 0 15,899,676 0% 7.99%
----------- ----------- ------- ----------- --------- ----------- ------- ------------
B. Qualifying Financial instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/Conversion Number of voting % of voting rights
instrument Date Period/Date rights that may
be acquired if
the instrument
if exercised/converted
----------- -------------------- ------------------------ -------------------
- - - - -
----------- -------------------- ------------------------ -------------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/Conversion Number of voting % of voting rights
financial Price Date Period/Date rights instrument
instrument refers to
--------- ----------- -------------------- ------------------- ---------------------
Nominal Delta
--------- ----------- -------------------- ------------------- ----------- --------
- - - - - - -
--------- ----------- -------------------- ------------------- ----------- --------
Total A+B+C
Number of Voting rights % of voting rights
-------------------
15,899,676 7.99
-------------------
9 Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable
Proxy Voting
10 Name of the proxy holder The Capital Group Companies, Inc
------------------------------ ---------------------------------
11 Number of voting rights proxy N/A
holder will cease to hold
------------------------------ ---------------------------------
12 Date on which proxy holder N/A
will cease to hold voting
rights
------------------------------ ---------------------------------
13 Additional Information
14 Contact name: Peter Speirs, Company Secretary
-------------------------- --------------------------------
15 Contact telephone number: 020 7399 2772
-------------------------- --------------------------------
- ENDS -
About Hikma
Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based primarily in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2014, Hikma achieved
revenues of $1,489 million and profit attributable to shareholders
of $278 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVSWRVBASARR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024